Ophthalmic Drugs Market is Expected to Witness Significant Growth in Healthcare Sector with a CAGR between 5.2% and 5.5% - PowerPoint PPT Presentation

About This Presentation
Title:

Ophthalmic Drugs Market is Expected to Witness Significant Growth in Healthcare Sector with a CAGR between 5.2% and 5.5%

Description:

Ophthalmic drugs are the drugs designed for the treatment of eye diseases and disorders. This administration of drug can be done by instillation of a cream, an ointment, or a liquid drop preparation in the conjunctiva sac. The correct strength and amount of the drug are selected, and the medication is instilled into the eye or eyes as directed. – PowerPoint PPT presentation

Number of Views:27

less

Transcript and Presenter's Notes

Title: Ophthalmic Drugs Market is Expected to Witness Significant Growth in Healthcare Sector with a CAGR between 5.2% and 5.5%


1
2016-2022
Ophthalmic Drugs Market is Expected to Witness
Significant Growth in Healthcare Sector with a
CAGR between 5.2 and 5.5
Infinium Global Research
2
Ophthalmic drugs are the drugs designed for the
treatment of eye diseases and disorders. This
administration of drug can be done by
instillation of a cream, an ointment, or a liquid
drop preparation in the conjunctiva sac. The
correct strength and amount of the drug are
selected, and the medication is instilled into
the eye or eyes as directed. The main reason of
continuingly strong interest of scientists in
these drugs forms is the problem of a low
bioavailability of medicinal substance after the
application to the eyeball. The ability to
increase the bioavailability of the active
substances, reducing the susceptibility of drug
forms to defense mechanisms of the human eye,
extending contact time of drug with the cornea,
increasing the penetration through the complex
anatomical structure of the eye, and providing
controlled release of drugs into the eye tissues
which allows reducing the drug application
frequency, witnesses the importance of ophthalmic
drugs among the aging population suffering from
eye disorders are some of the factors
contributing to the growth in the global
ophthalmic drugs market. For Sample Pages of this
Report https//www.infiniumglobalresearch.com/Rep
orts/MakeSampleRequest/165 Global Ophthalmic
Drugs Market is projected to Grow with a CAGR
between 5.2 and 5.5 Over the Forecast Period
of 2016 2022 The report segments the
Ophthalmic Drugs Market by Disease Condition and
by Dispense Type.
3
  • The Companies Covered in this Research Report
  • Abbott Healthcare
  • Allergan Plc
  • Johnson Johnson
  • Bayer
  • Valeant Pharmaceuticals, Inc
  • Pfizer Inc
  • Merck Co
  • Novartis AG
  • Renegeron
  • Santen Pharmaceuticals Company Ltd
  • To Make an Enquiry about this Report
  • https//www.infiniumglobalresearch.com/Reports/Mak
    eEnquiryRequest/165
Write a Comment
User Comments (0)
About PowerShow.com